-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Risk Stratification in MDS

Program: Education Program
Session: Myelodysplastic Syndromes: What We Have and What We Want
Hematology Disease Topics & Pathways:
Diseases, Bone Marrow Failure, Elderly, MDS, Biological Processes, Study Population, Myeloid Malignancies, genomics, Clinically relevant, immune mechanism, inflammation, microenvironment, molecular interactions
Saturday, December 5, 2020, 9:25 AM-9:30 AM

Uwe Platzbecker, MD

Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

Disclosures: Platzbecker: Amgen: Honoraria, Research Funding; Bergenbio: Research Funding; JAZZ: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Novartis: Honoraria, Research Funding; BMS: Honoraria, Research Funding.

Previous Presentation | Next Presentation >>